Skip to navigation | Skip to main content | Skip to footer

We welcome your feedback

Please help us improve The University of Manchester website by completing a short questionnaire at the end of your visit.

Yes, I'll give feedback No, thanks

Read our privacy notice

Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Eleanor Cheadle (PhD, BSc (Hons), FHEA) - research

Research interests

My research interests lie in  immunotherapy of B-cell malignancies. I am particularly interested in ways to improve the generation of effective anti-tumour T-cell immune responses post anti-CD20 monoclonal antibody therapy. My research currently focuses on a number of ways to improve anti-CD20 mAb therapy such as combining therapy with immunomodulatory agents, radiation and manipulation of the tumour microenvironment. We are particularly interested in the novel type II anti-CD20 mAb Obinutuzumab and how its mechanism of action compares to type I rituximab. I am also interested in adoptive cell therapy, in particular gene modified T-cells expressing CD19 specific chimeric antigen receptors.


Collaborators and affiliated staff